Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

John Colwell

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Anatomy

Blood Platelets

Physiology

Platelet Aggregation

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
25
Lopes-Virella, Maria
16
Halushka, Perry
15
Sagel, Julius
15
Abraira, Carlos
13
Comstock, JP
13
Nuttall, FQ
11
Sawin, Clark
11
Emanuele, Nicholas
11
Mayfield, Ronald
9
Virella, Gabriel
8
Silbert, CK
7
Bingham, Stephen
7
Levin, SR
6
Henderson, WG
4
Klein, Richard

Sign-in to see all Coauthors

Publications

TOP 3
Colwell John A
Does aspirin use reduce cardiovascular risk in diabetes?
Mountford William K; Lackland Daniel T; Soule Jeremy B; Hunt Kelly J; Lipsitz Stuart R; Colwell John A
Racial disparities in trends for cardiovascular disease and procedures among hospitalized diabetic patients.
Mountford William K; Soule Jeremy B; Lackland Daniel T; Lipsitz Stuart R; Colwell John A
Diabetes-related lower extremity amputation rates fall significantly in South Carolina.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of John Colwell (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Colwell John A
Does aspirin use reduce cardiovascular risk in diabetes?
Nature reviews. Endocrinology 2009;5(4):188-90.
2008: Mountford William K; Lackland Daniel T; Soule Jeremy B; Hunt Kelly J; Lipsitz Stuart R; Colwell John A
Racial disparities in trends for cardiovascular disease and procedures among hospitalized diabetic patients.
Ethnicity & disease 2008;18(2):131-5.
2007: Mountford William K; Soule Jeremy B; Lackland Daniel T; Lipsitz Stuart R; Colwell John A
Diabetes-related lower extremity amputation rates fall significantly in South Carolina.
Southern medical journal 2007;100(8):787-90.
2006: Colwell John A
An appraisal of aspirin therapy in diabetes.
Current diabetes reports 2006;6(6):409-10.
2006: Koopman Richelle J; Mainous Arch G; Liszka Heather A; Colwell John A; Slate Elizabeth H; Carnemolla Mark A; Everett Charles J
Evidence of nephropathy and peripheral neuropathy in US adults with undiagnosed diabetes.
Annals of family medicine 2006;4(5):427-32.
2006: Colwell John A
Aspirin for the primary prevention of cardiovascular events.
Drugs of today (Barcelona, Spain : 1998) 2006;42(7):467-79.
2006: Colwell John A
Aspirin for the primary prevention of cardiovascular events.
Timely topics in medicine. Cardiovascular diseases 2006;10():E25.
2005: Colwell J A
Is aspirin effective in diabetic patients? Yes.
Journal of thrombosis and haemostasis : JTH 2005;3(12):2612-4.
2004: Colwell John A;
Aspirin therapy in diabetes.
Diabetes care 2004;27 Suppl 1():S72-3.
2004: Colwell John A
Antiplatelet agents for the prevention of cardiovascular disease in diabetes mellitus.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2004;4(2):87-106.
2003: Colwell John A
Aspirin for primary prevention of cardiovascular events in diabetes.
Diabetes care 2003;26(12):3349-50.
2003: Colwell John A; Nesto Richard W
The platelet in diabetes: focus on prevention of ischemic events.
Diabetes care 2003;26(7):2181-8.
2003: Colwell John A;
Aspirin therapy in diabetes.
Diabetes care 2003;26 Suppl 1():S87-8.
2002: Colwell John A
Hemoglobin A1c is not the only issue.
Current diabetes reports 2002;2(4):295-6.
2001: Colwell J A
Treatment for the procoagulant state in type 2 diabetes.
Endocrinology and metabolism clinics of North America 2001;30(4):1011-30.
2001: Colwell J A
Aspirin therapy in diabetes is underutilized.
Diabetes care 2001;24(2):195-6.
2000: Colwell J
Pathogenesis of vascular disease.
Diabetes, obesity & metabolism 2000;2 Suppl 2():S19-24.
2000: Olson J W; Shernoff A F; Tarlow J L; Colwell J A; Scheetz J P; Bingham S F
Dental endosseous implant assessments in a type 2 diabetic population: a prospective study.
The International journal of oral & maxillofacial implants 2000;15(6):811-8.
2000: Levin S R; Coburn J W; Abraira C; Henderson W G; Colwell J A; Emanuele N V; Nuttall F Q; Sawin C T; Comstock J P; Silbert C K
Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators.
Diabetes care 2000;23(10):1478-85.
2000: Colwell J A; Keisler D; Todd-Heckel E; Arnold P; Jenkins C
New legislation covers reimbursement and diabetes care guidelines.
Journal of the South Carolina Medical Association (1975) 2000;96(9):382-5.
2000: Pitale S U; Abraira C; Emanuele N V; McCarren M; Henderson W G; Pacold I; Bushnell D; Colwell J A; Nuttall F Q; Levin S R; Sawin C T; Comstock J P; Silbert C K
Two years of intensive glycemic control and left ventricular function in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM).
Diabetes care 2000;23(9):1316-20.
1999: Azad N; Emanuele N V; Abraira C; Henderson W G; Colwell J; Levin S R; Nuttall F Q; Comstock J P; Sawin C T; Silbert C; Rubino F A
The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM).
Journal of diabetes and its complications 1999;13(5-6):307-13.
1999: Colwell J A
Aspirin and risk of hemorrhagic stroke.
JAMA : the journal of the American Medical Association 1999;282(8):731-2; author reply 732-3.
1998: Emanuele N; Azad N; Abraira C; Henderson W; Colwell J; Levin S; Nuttall F; Comstock J; Sawin C; Silbert C; Marcovina S; Lee H S
Effect of intensive glycemic control on fibrinogen, lipids, and lipoproteins: Veterans Affairs Cooperative Study in Type II Diabetes Mellitus.
Archives of internal medicine 1998;158(22):2485-90.
1998: Willi S M; O'Rear D; Garvey W T; Colwell J A; Buse M G; Jaffa A; Lopes-Virella M; Wood D; Mayfield R K; Wallace P; Hermayer K L; Jenkins A J; Lyons T; Mayer-Davis E
Diabetes research in South Carolina: past, present, and future.
Journal of the South Carolina Medical Association (1975) 1998;94(11):502-8.
1998: Colwell J A; Keisler D; Jenkins C; Boateng Y; Arnold P; Lackland D; Zheng D; Wheeler F C; Rosebrock G; Smith S H
Overview of the Diabetes Initiative of South Carolina.
Journal of the South Carolina Medical Association (1975) 1998;94(11):468-72.
1998: Abraira C; Colwell J A; Nuttall F; Emanuele N; Comstock J; Levin S; Sawin C; Silbert C
A critical issue. Intensive insulin treatment and macrovascular disease.
Diabetes care 1998;21(4):669-71.
1998: Abraira C; Henderson W G; Colwell J A; Nuttall F Q; Comstock J P; Emanuele N V; Levin S R; Sawin C T; Silbert C K
Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).
Diabetes care 1998;21(4):574-9.
1998: Agrawal L; Emanuele N V; Abraira C; Henderson W G; Levin S R; Sawin C T; Silbert C K; Nuttall F Q; Comstock J P; Colwell J A
Ethnic differences in the glycemic response to exogenous insulin treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM).
Diabetes care 1998;21(4):510-5.
1998: Colwell J A
Prevention of diabetes complications.
Clinical cornerstone 1998;1(3):58-71.
1997: Colwell J A
Multifactorial aspects of the treatment of the type II diabetic patient.
Metabolism: clinical and experimental 1997;46(12 Suppl 1):1-4.
1997: Zheng D; Learner M; Wheeler F C; Macera C A; Boateng Y; Shepard D M; Colwell J A
Preventive care among people with diabetes in biracial population.
Journal of the South Carolina Medical Association (1975) 1997;93(12):443-7.
1997: Colwell J A
Elevated plasma homocysteine and diabetic vascular disease.
Diabetes care 1997;20(12):1805-6.
1997: Colwell J A
Controlling type 2 diabetes: are the benefits worth the costs?
JAMA : the journal of the American Medical Association 1997;278(20):1700.
1997: Colwell J A
Aspirin therapy in diabetes.
Diabetes care 1997;20(11):1767-71.
1997: Colwell J A
Pharmacological strategies to prevent macrovascular disease in NIDDM.
Diabetes 1997;46 Suppl 2():S131-4.
1997: Colwell J A
Aspirin therapy in diabetes mellitus.
Diabetologia 1997;40(7):867.
1997: Abraira C; Colwell J; Nuttall F; Sawin C T; Henderson W; Comstock J P; Emanuele N V; Levin S R; Pacold I; Lee H S
Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes.
Archives of internal medicine 1997;157(2):181-8.
1996: Emanuele N; Klein R; Abraira C; Colwell J; Comstock J; Henderson W G; Levin S; Nuttall F; Sawin C; Silbert C; Lee H S; Johnson-Nagel N
Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study.
Diabetes care 1996;19(12):1375-81.
1996: Colwell J A
Should we use intensive insulin therapy after oral agent failure in type II diabetes?
Diabetes care 1996;19(8):896-8.
1996: Colwell J A
Intensive insulin therapy in type II diabetes: rationale and collaborative clinical trial results.
Diabetes 1996;45 Suppl 3():S87-90.
1996: Colwell J A; Clark C M
Forum Two: Unanswered research questions about metabolic control in non-insulin-dependent diabetes mellitus.
Annals of internal medicine 1996;124(1 Pt 2):178-9.
1996: Colwell J A
The feasibility of intensive insulin management in non-insulin-dependent diabetes mellitus. Implications of the Veterans Affairs Cooperative Study on Glycemic Control and Complications in NIDDM.
Annals of internal medicine 1996;124(1 Pt 2):131-5.
1995: Jokl R; Klein R L; Lopes-Virella M F; Colwell J A
Release of platelet plasminogen activator inhibitor 1 in whole blood is increased in patients with type II diabetes.
Diabetes care 1995;18(8):1150-5.
1995: Abraira C; Colwell J A; Nuttall F Q; Sawin C T; Nagel N J; Comstock J P; Emanuele N V; Levin S R; Henderson W; Lee H S
Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
Diabetes care 1995;18(8):1113-23.
1994: Jokl R; Laimins M; Klein R L; Lyons T J; Lopes-Virella M F; Colwell J A
Platelet plasminogen activator inhibitor 1 in patients with type II diabetes.
Diabetes care 1994;17(8):818-23.
1994: Shernoff A F; Colwell J A; Bingham S F
Implants for type II diabetic patients: interim report. VA Implants in Diabetes Study Group.
Implant dentistry 1994;3(3):183-5.
1993: Colwell J A
Is it time to introduce metformin in the U.S.?
Diabetes care 1993;16(4):653-5.
1993: Vinik A I; Colwell J A
Effects of gemfibrozil on triglyceride levels in patients with NIDDM. Hyperlipidemia in Diabetes Investigators.
Diabetes care 1993;16(1):37-44.
1993: Colwell J A
Vascular thrombosis in type II diabetes mellitus.
Diabetes 1993;42(1):8-11.
1992: Abraira C; Emanuele N; Colwell J; Henderson W; Comstock J; Levin S; Nuttall F; Sawin C
Glycemic control and complications in type II diabetes. Design of a feasibility trial. VA CS Group (CSDM)
Diabetes care 1992;15(11):1560-71.
1992: Colwell J A
Antiplatelet drugs and prevention of macrovascular disease in diabetes mellitus.
Metabolism: clinical and experimental 1992;41(5 Suppl 1):7-10.
1991: Colwell J A
Clinical trials of antiplatelet agents in diabetes mellitus: rationale and results.
Seminars in thrombosis and hemostasis 1991;17(4):439-44.
1991: Colwell J A
Pathophysiology of vascular disease in diabetes: effects of gliclazide.
The American journal of medicine 1991;90(6A):50S-54S.
1991: Colwell J A
Oral treatment of diabetes mellitus: the contribution of gliclazide.
The American journal of medicine 1991;90(6A):1S-2S.
1990: Gisinger C; Watanabe J; Colwell J A
Vitamin E and platelet eicosanoids in diabetes mellitus.
Prostaglandins, leukotrienes, and essential fatty acids 1990;40(3):169-76.
1990: Hornsby W G; Boggess K A; Lyons T J; Barnwell W H; Lazarchick J; Colwell J A
Hemostatic alterations with exercise conditioning in NIDDM.
Diabetes care 1990;13(2):87-92.
1989: Colwell J A; Bingham S F; Abraira C; Anderson J W; Comstock J P; Kwaan H C; Nuttall F
V.A. Cooperative Study of antiplatelet agents in diabetic patients after amputation for gangrene: unobserved, sudden, and unexpected deaths.
The Journal of diabetic complications 1989;3(4):191-7.
1988: Watanabe J; Wohltmann H J; Klein R L; Colwell J A; Lopes-Virella M F
Enhancement of platelet aggregation by low-density lipoproteins from IDDM patients.
Diabetes 1988;37(12):1652-7.
1988: Colwell J A; Lopes-Virella M F
A review of the development of large-vessel disease in diabetes mellitus.
The American journal of medicine 1988;85(5A):113-8.
1988: Colwell J A
President's address.
Diabetes 1988;37(11):1449-52.
1987: Lopes-Virella M F; Colwell J A
Pharmacological treatment of lipid disorders in diabetes mellitus.
Diabetes/metabolism reviews 1987;3(3):691-722.
1987: Colwell J A
Antiplatelet agents and diabetic vascular disease.
Transactions of the American Clinical and Climatological Association 1987;98():119-27.
1986: Lyons T J; Baynes J W; Patrick J S; Colwell J A; Lopes-Virella M F
Glycosylation of low density lipoprotein in patients with type 1 (insulin-dependent) diabetes: correlations with other parameters of glycaemic control.
Diabetologia 1986;29(10):685-9.
1986: Colwell J A; Bingham S F; Abraira C; Anderson J W; Comstock J P; Kwaan H C; Nuttall F
Veterans Administration Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: II. Effects of aspirin and dipyridamole on atherosclerotic vascular disease rates.
Diabetes care 1986;9(2):140-8.
1986: Colwell J A; Bingham S F
VA cooperative study on antiplatelet agents in diabetic patients after amputation for gangrene. IV. Issues in design, interpretation, and analysis.
Haemostasis 1986;16(6):433-8.
1986: Colwell J A
Effects of exercise on platelet function, coagulation, and fibrinolysis.
Diabetes/metabolism reviews 1986;1(4):501-12.
1985: Halushka P V; Mayfield R; Colwell J A
Insulin and arachidonic acid metabolism in diabetes mellitus.
Metabolism: clinical and experimental 1985;34(12 Suppl 1):32-6.
1985: Lopes-Virella M F; Sherer G; Wohltmann H; Sens D; Colwell J A
Diabetic lipoprotein deficient serum: its effect in low density lipoprotein (LDL) uptake and degradation by fibroblasts.
Metabolism: clinical and experimental 1985;34(12):1079-85.
1985: Mayfield R K; Halushka P V; Wohltmann H J; Lopes-Virella M; Chambers J K; Loadholt C B; Colwell J A
Platelet function during continuous insulin infusion treatment in insulin-dependent diabetic patients.
Diabetes 1985;34(11):1127-33.
1985: Winocour P D; Lopes-Virella M; Laimins M; Colwell J A
Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen.
The Journal of laboratory and clinical medicine 1985;106(3):319-25.
1985: Winocour P D; Colwell J A
Reduced platelet-mediated and enhanced leukocyte-mediated fibrinolysis in experimentally induced diabetes in rats.
The Journal of laboratory and clinical medicine 1985;105(5):613-8.
1985: Colwell J A; Bingham S F; Abraira C; Anderson J W; Kwaan H C
V.A. Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: III. Definitions and review of design and baseline characteristics.
Hormone and metabolic research. Supplement series 1985;15():69-73.
1984: Mayfield R K; Margolius H S; Levine J H; Wohltmann H J; Loadholt C B; Colwell J A
Urinary kallikrein excretion in insulin-dependent diabetes mellitus and its relationship to glycemic control.
The Journal of clinical endocrinology and metabolism 1984;59(2):278-86.
1984: Winocour P D; Laimins M; Colwell J A
Platelet survival in streptozotocin-induced diabetic rats.
Thrombosis and haemostasis 1984;51(3):307-12.
1984: Colwell J A; Bingham S F; Abraira C; Anderson J W; Kwaan H C
V.A. Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: I. Design, methods, and baseline characteristics.
Controlled clinical trials 1984;5(2):165-83.
1983: Colwell J A; Winocour P D; Lopes-Virella M; Halushka P V
New concepts about the pathogenesis of atherosclerosis in diabetes mellitus.
The American journal of medicine 1983;75(5B):67-80.
1983: Winocour P D; Lopes-Virella M; Laimins M; Colwell J A
Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
The Journal of laboratory and clinical medicine 1983;102(5):795-804.
1983: Mayfield R K; Sullivan F M; Colwell J A; Wohltmann H J
Predicting insulin requirements for a portable insulin pump using the Biostator. Evidence for reversible insulin resistance in poorly controlled type I diabetics.
Diabetes 1983;32(10):908-14.
1983: Virella G; Lopes-Virella M F; Shuler C; Sherwood T; Espinoza G A; Winocour P; Colwell J A
Release of PAF by human polymorphonuclear leucocytes stimulated by immune complexes bound to Sepharose particles and human erythrocytes.
Immunology 1983;50(1):43-51.
1983: Mordes D B; Lazarchick J; Colwell J A; Sens D A
Elevated glucose concentrations increase factor VIIIR:Ag levels in human umbilical vein endothelial cells.
Diabetes 1983;32(9):876-8.
1983: Colwell J A; Winocour P D; Halushka P V
Do platelets have anything to do with diabetic microvascular disease?
Diabetes 1983;32 Suppl 2():14-9.
1983: Detrisac C J; Mayfield R K; Colwell J A; Garvin A J; Sens D A
In vitro culture of cells exfoliated in the urine by patients with diabetes mellitus.
The Journal of clinical investigation 1983;71(1):170-3.
1983: Lopes-Virella M F; Wohltmann H J; Mayfield R K; Loadholt C B; Colwell J A
Effect of metabolic control on lipid, lipoprotein, and apolipoprotein levels in 55 insulin-dependent diabetic patients. A longitudinal study.
Diabetes 1983;32(1):20-5.
1982: Virella G; Espinoza A; Patrick H; Colwell J A
Polymorphonuclear leucocytes release a factor(s) that induces platelet aggregation and ATP release after interaction with insoluble and surface-fixed immune complexes.
Clinical and experimental immunology 1982;49(3):684-94.
1982: Mordes D; Kreutner K; Metzger W; Colwell J A
Dangers of intravenous ritodrine in diabetic patients.
JAMA : the journal of the American Medical Association 1982;248(8):973-5.
1982: Lopes-Virella M F; Sherer G K; Lees A M; Wohltmann H; Mayfield R; Sagel J; LeRoy E C; Colwell J A
Surface binding, internalization and degradation by cultured human fibroblasts of low density lipoproteins isolated from type 1 (insulin-dependent) diabetic patients: changes with metabolic control.
Diabetologia 1982;22(6):430-6.
1982: Colwell J A; Halushka P V
Platelets, prostaglandins, and coagulation in diabetes mellitus.
The Mount Sinai journal of medicine, New York 1982;49(3):215-22.
1981: Virella G; Wohltmann H; Sagel J; Lopes-Virella M F; Kilpatrick M; Phillips C; Colwell J
Soluble immune complexes in patients with diabetes mellitus: detection and pathological significance.
Diabetologia 1981;21(3):184-91.
1981: Van Zile J; Kilpatrick M; Laimins M; Sagel J; Colwell J; Virella G
Platelet aggregation and release of ATP after incubation with soluble immune complexes purified from the serum of diabetic patients.
Diabetes 1981;30(7):575-9.
1981: Colwell J A
Studies on the pathogenesis of diabetic vascular disease.
Journal of the South Carolina Medical Association (1975) 1981;77(6):267-72.
1981: Halushka P V; Rogers R C; Loadholt C B; Colwell J A
Increased platelet thromboxane synthesis in diabetes mellitus.
The Journal of laboratory and clinical medicine 1981;97(1):87-96.
1981: Colwell J A; Lopes-Virella M; Halushka P V
Pathogenesis of atherosclerosis in diabetes mellitus.
Diabetes care 1981;4(1):121-33.
1981: Halushka P V; Rogers R C; Loadholt C B; Wohltman H; Mayfield R; McCoy S; Colwell J A
Increased platelet prostaglandin and thromboxane synthesis in diabetes mellitus.
Hormone and metabolic research. Supplement series 1981;11():7-11.
1981: Colwell J A
Atherosclerosis in diabetes mellitus.
Journal of chronic diseases 1981;34(1):1-4.
1981: Colwell J A; Van Zile J; Kilpatrick J M; Nair R M; Virella G
Plasma factors and platelet aggregation in diabetes mellitus.
Hormone and metabolic research. Supplement series 1981;11():1-6.
1981: Halushka P V; Mayfield R; Wohltmann H J; Rogers R C; Goldberg A K; McCoy S A; Loadholt C B; Colwell J A
Increased platelet arachidonic acid metabolism in diabetes mellitus.
Diabetes 1981;30(Suppl 2):44-8.
1980: Virella G; Russell D; Laimins M; Colwell J
Simplified method for detecting anti-insulin antibodies and insulin-anti-insulin immune complexes.
Clinical chemistry 1980;26(9):1357-9.
1980: Lopes-Virella M F; Virella G; Evans G; Malenkos S B; Colwell J A
Immunonephelometric assay of human apolipoprotein AI.
Clinical chemistry 1980;26(8):1205-8.
1980: Colwell J A; Halushka P V
Platelet function in diabetes mellitus.
British journal of haematology 1980;44(4):521-6.
1980: Mayfield R K; Sagel J; Colwell J A
Thyrotoxicosis without elevated serum triiodothyronine levels during diabetic ketoacidosis.
Archives of internal medicine 1980;140(3):408-10.
1980: Gonzalez J; Colwell J A; Sarji K E; Nair R M; Sagel J
Effect of metabolic control with insulin on plasma von Willebrand factor activity (VIIIR:WF) in diabetes mellitus.
Thrombosis research 1980;17(1-2):261-6.
1979: Sagel J; Lopes-Virella M F; Levine J H; Colwell J A
Decreased high density lipoprotein cholesterol in hypopituitarism.
The Journal of clinical endocrinology and metabolism 1979;49(5):753-6.
1979: Lopes-Virella M; Virella G; Debeukelaer M; Owens C J; Colwell J A
Urinary high density lipoprotein in minimal change glomerular disease and chronic glomerulopathies.
Clinica chimica acta; international journal of clinical chemistry 1979;94(1):73-81.
1979: Colwell J A; Nair R M; Halushka P V; Rogers C; Whetsell A; Sagel J
Platelet adhesion and aggregation in diabetes mellitus.
Metabolism: clinical and experimental 1979;28(4 Suppl 1):394-400.
1979: Colwell J A; Halushka P V; Sarji K E; Lopes-Virella M F; Sagel J
Vascular disease in diabetes: pathophysiological mechanisms and therapy.
Archives of internal medicine 1979;139(2):225-30.
1979: Sarji K E; Eurenius K; Fullwood C O; Schraibman H B; Colwell J A
Abnormalities of platelet aggregation in sickle cell anemia. Presence of a plasma factor inhibiting aggregation by ristocetin.
Thrombosis research 1979;14(2-3):283-97.
1979: Sarji K E; Kleinfelder J; Brewington P; Gonzalez J; Hempling H; Colwell J A
Decreased platelet vitamin C in diabetes mellitus: possible role in hyperaggregation.
Thrombosis research 1979;15(5-6):639-50.
1978: Colwell J A; Halushka P V; Sarji K E; Sagel J
Platelet function and diabetes mellitus.
The Medical clinics of North America 1978;62(4):753-66.
1978: Colwell J A; Halushka P V; Sarji K E; Sagal J
Rationale for antiplatelet agents in diabetic vascular disease.
Advances in experimental medicine and biology 1978;102():243-54.
1977: Halushka P V; Lurie D; Colwell J A
Increased synthesis of prostaglandin-E-like material by platelets from patients with diabetes mellitus.
The New England journal of medicine 1977;297(24):1306-10.
1977: Colwell J A
Hypoglycemia.
Primary care 1977;4(4):681-92.
1977: Sarji K E; Levine J H; Nair R M; Sagel J; Colwell J A
Relation between growth hormone levels and Von Willebrand factor activity.
The Journal of clinical endocrinology and metabolism 1977;45(4):853-6.
1977: Lopes-Virella M F; Stone P G; Colwell J A
Serum high density lipoprotein in diabetic patients.
Diabetologia 1977;13(4):285-91.
1977: Graves J M; Colwell J A; Nair R M; Sarji K E
The effect of oral glucose on von Willebrand factor activity in normal and diabetic subjects.
Clinical endocrinology 1977;6(6):437-42.
1977: Lopes-Virella M F; Stone P; Ellis S; Colwell J A
Cholesterol determination in high-density lipoproteins separated by three different methods.
Clinical chemistry 1977;23(5):882-4.
1977: Colwell J A; Sagel J; Crook L; Chambers A; Laimins M
Correlation of platelet aggregation, plasma factor activity, and megathrombocytes in diabetic subjects with an without vascular disease.
Metabolism: clinical and experimental 1977;26(3):279-85.
1977: Braunstein K M; Sarji K E; Kleinfelder J; Schraibman H B; Colwell J A; Eurenius K
The effects of dopamine on human platelet aggregation, in vitro.
The Journal of pharmacology and experimental therapeutics 1977;200(2):449-57.
1976: Fritz S D; Fitts C T; Colwell J A
Glucose and insulin responses in sheep subjected to a second episode of hemorrhagic shock.
The American surgeon 1976;42(12):899-907.
1976: Colwell J A
Treatment of diabetes mellitus.
Comprehensive therapy 1976;2(11):16-21.
1976: Lopes-Virella M F; Sarji K; Virella G; Colwell J A
Platelet lipoproteins. A comparative study with serum lipoproteins.
Biochimica et biophysica acta 1976;439(2):339-48.
1976: Lopes-Virella M F; Colwell J A
Serum-high-density-lipoprotein in diabetic patients.
Lancet 1976;1(7972):1291-2.
1976: Colwell J A
Use of oral agents in treating diabetes mellitus a perspective.
Postgraduate medicine 1976;59(1):139-44.
1976: Colwell J A; Halushka P V; Sarji K; Levine J; Sagel J; Nair R M
Altered platelet function in diabetes mellitus.
Diabetes 1976;25(2 SUPPL):826-31.
1975: Bell N H; Del Greco F; Colwell J A
Primary hyperparathyroidism and salt-wasting nephropathy.
Journal of chronic diseases 1975;28(11-12):601-7.
1975: Sarji K E; Graves J M; Colwell J A
Von Willebrand factor activity in normal subjects: sex difference and variability.
Thrombosis research 1975;7(6):885-95.
1975: Colwell J A; Chambers A; Laimins M
Inhibition of labile aggregation-stimulating substance (LASS) and platelet aggregation in diabetes mellitus.
Diabetes 1975;24(7):684-7.
1975: Sagel J; Colwell J A; Crook L; Laimins M
Increased platelet aggregation in early diabetus mellitus.
Annals of internal medicine 1975;82(6):733-8.
1974: McGuigan J E; Colwell J A; Franklin J
Effect of parathyroidectomy on hypercalcemic hypersecretory peptic ulcer disease.
Gastroenterology 1974;66(2):269-72.
1973: Sagel J; Colwell J A
Shock during oral glucose tolerance testing.
JAMA : the journal of the American Medical Association 1973;226(6):667-8.
1973: Sagel J; Colwell J A; Loadholt C B; Lizarralde G
Circadian rhythm in the urinary excretion of cyclic 3',5'-adenosine monophosphate in man.
The Journal of clinical endocrinology and metabolism 1973;37(4):570-3.
1973: Dobbie J G; Kwaan H C; Colwell J A; Suwanwela N
The role of platelets in pathogenesis of diabetic retinopathy.
Transactions - American Academy of Ophthalmology and Otolaryngology. American Academy of Ophthalmology and Otolaryngology 1973;77(1):OP43-7.
1972: Rabkin R; Rubenstein A H; Colwell J A
Glomerular filtration and proximal tubular absorption of insulin 125 I.
The American journal of physiology 1972;223(5):1093-6.
1972: Kwaan H C; Colwell J A; Cruz S; Suwanwela N; Dobbie J G
Increased platelet aggregation in diabetes mellitus.
The Journal of laboratory and clinical medicine 1972;80(2):236-46.
1972: Cruz S R; Colwell J A
Pheochromocytoma and ileus.
JAMA : the journal of the American Medical Association 1972;219(8):1050-1.
1972: Kwaan H C; Colwell J A; Suwanwela N
Disseminated intravascular coagulation in diabetes mellitus, with reference to the role of increased platelet aggregation.
Diabetes 1972;21(2):108-13.
1972: Colwell J A; Cruz S R
Effect of resection of adipose tissue on the diabetes and hyperinsulinism of benign symmetric lipomatosis.
Diabetes 1972;21(1):13-5.
1971: Kwaan H C; Colwell J A; Cruz S; Suwanwela N; Dobbie J G
Increased platelet aggregation in diabetes mellitus.
The Journal of laboratory and clinical medicine 1971;78(5):844-5.
1971: Colwell J A; Wilber J F
Studies of insulin and growth hormone secretion in a subject with hepatoma and gypoglycemia.
Diabetes 1971;20(9):607-14.
1971: Merkel F K; Poticha S M; Nudelman E J; Colwell J A; Bergan J J
Pancreas transplantation in man. I. The donor and recipient operation.
Archives of surgery (Chicago, Ill. : 1960) 1971;103(2):205-10.
1970: Colwell J A
Do we need a new way to treat diabetes mellitus?
Journal of chronic diseases 1970;23(4):209-12.
1970: Rabkin R; Simon N M; Steiner S; Colwell J A
Effect of renal disease on renal uptake and excretion of insulin in man.
The New England journal of medicine 1970;282(4):182-7.
1969: Colwell J A
Pheochromocytoma and insulin.
Annals of internal medicine 1969;71(3):668-9.
1969: Colwell J A
Inhibition of insulin secretion by catecholamines in pheochromocytoma.
Annals of internal medicine 1969;71(2):251-6.
1969: Rabkin R; Colwell J A
The renal uptake and excretion of insulin in the dog.
The Journal of laboratory and clinical medicine 1969;73(6):893-900.
1968: Hershman J M; Craane T J; Colwell J A
Effect of sulfonylurea drugs on the binding of triiodothyronine and thyroxine to thyroxine-binding globulin.
The Journal of clinical endocrinology and metabolism 1968;28(11):1605-10.
1968: Colwell J A; Furey W L
Insulin secretion by insuloma and normal pancreas slices. Studies in a patient with multiple endocrine adenomata.
Diabetes 1968;17(2):83-9.
1967: Faiman C; Colwell J A; Ryan R J; Hershman J M; Shields T W
Gonadotropin secretion from a bronchogenic carcinoma. Demonstration by radioimmunoassay.
The New England journal of medicine 1967;277(26):1395-9.
1967: Colwell J A; Lein A
Diminished insulin response to hyperglycemia in prediabetes and diabetes.
Diabetes 1967;16(8):560-5.
1966: Bell N H; Colwell J A; Saval F; Del Greco F; Casey D E
Effects of calcium infusion on urinary hydroxyproline and phosphorus: evaluation as a diagnostic test.
The Journal of clinical endocrinology and metabolism 1966;26(7):677-82.
1966: Colwell J A
Effect of diabetic control on retinopathy.
Diabetes 1966;15(7):497-9.
1966: Colwell J A; Colwell A R
Effect of insulin infusion of pancreas on blood glucose.
Diabetes 1966;15(2):123-6.
1964: PATTERSON R; COLWELL J A; GREGOR W H; CARY E
AVIAN ANTI-INSULIN SERUM: A COMPARISON OF ITS IMMUNOLOGIC AND BIOLOGIC ACTIVITY WITH THAT OF GUINEA PIG AND RABBIT ANTISERA.
The Journal of laboratory and clinical medicine 1964;64():399-411.
1963: COLWELL J A; LEIN A
QUANTITATIVE RELATIONSHIP BETWEEN PLASMA CONCENTRATION OF FATTY ACIDS AND GLUCOSE IN NORMAL AND DIABETIC DOGS.
Diabetes 1963;12():424-8.
1963: COLWELL J A; LEIN A
EFFECT OF SITE OF ADMINISTRATION OF INSULIN ON BLOOD GLUCOSE AND FATTY ACID CONCENTRATIONS.
Diabetes 1963;12():319-22.
1961: COLWELL J A; TILLMAN S P
Early recognition and therapy of disseminated coccidioidomycosis.
The American journal of medicine 1961;31():676-91.
1959: COLWELL J A
Remission in disseminated coccidiodomycosis produced by amphotericin B.
Annals of internal medicine 1959;50(4):1028-35.
1959: COLWELL A R; COLWELL J A
Pancreatic action of the sulfonylureas.
The Journal of laboratory and clinical medicine 1959;53(3):376-95.
1957: COLWELL A R; COLWELL J A; COLWELL A R
Perfusion studies with sulfonylureas in dogs.
Annals of the New York Academy of Sciences 1957;71(1):125-30.
1957: COLWELL A R; COLWELL J A
Intrapancreatic infusions of the sulfonylureas.
Diabetes 1957;6(1):60; discussion, 62.
1957: COLWELL A R; COLWELL J A
Clinical use of oral sulfonylurea compounds in diabetes mellitus.
Quarterly bulletin. Northwestern University (Evanston, Ill.). Medical School 1957;31(2):102-13.
1956: COLWELL A R; COLWELL A R; COLWELL J A
Intrapancreatic perfusion of the antidiabetic sulfonylureas.
Metabolism: clinical and experimental 1956;5(6 Part 2):749-56.

Sign-in to see more